| 1 |
Jasso-Baltazar EA， Peãa-Arellano GA， Aguirre-Valadez J， et al.Portopulmonary hypertension：an updated review［J］. Transplant Direct， 2023， 9（8）：e1517.
|
| 2 |
Yoshida H， Shimizu T， Yoshioka M， et al. The role of the spleen in portal hypertension［J］. J Nippon Med Sch， 2023， 90（1）：20-25.
|
| 3 |
Gallo P， Terracciani F， Di Pasquale G， et al. Thrombocytopenia in chronic liver disease：physiopathology and new therapeutic strategies before invasive procedures［J］. World J Gastroenterol， 2022， 28（30）：4061-4074.
|
| 4 |
Lim HI， Cuker A. Thrombocytopenia and liver disease：pathophysiology and periprocedural management［J］. Hematology Am Soc Hematol Educ Program， 2022，（1）：296-302.
|
| 5 |
Yanaga K， Tzakis AG， Shimada M， et al. Reversal of hypersplenism following orthotopic liver transplantation［J］. Ann Surg， 1989， 210（2）：180-183.
|
| 6 |
Lu YF， Li XQ， Han XY， et al. Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism［J］. Asian Pac J Trop Med， 2013， 6（8）：663-666.
|
| 7 |
贺健， 郭庆军， 谢炎， 等. 应用影像后处理技术测定脾体积评估原位肝移植缓解脾功能亢进的效果［J］. 中华器官移植杂志，2019， 40（2）：107-110.
|
| 8 |
夏强， 沙朦. 活体肝移植的进展与展望［J］. 中华消化外科杂志，2022， 21（1）：39-42.
|
| 9 |
Coelho JC， Balbinot P， Nitsche R， et al. Change in platelet count in patients with hypersplenism subjected to liver transplantation［J］. Arq Gastroenterol， 2011， 48（3）：175-178.
|
| 10 |
Ishigami M， Ishizu Y， Onishi Y， et al. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology［J］.Springerplus， 2013， 2：374.
|
| 11 |
Ikegami T， Soejima Y， Taketomi A， et al. Hypersplenism after living donor liver transplantation［J］. Hepatogastroenterology， 2009， 56（91-92）：778-782.
|
| 12 |
Matsuura T， Hayashida M， Saeki I， et al. The risk factors of persistent thrombocytopenia and splenomegaly after liver transplantation［J］.Pediatr Surg Int，2010，26（10）：1007-1010.
|
| 13 |
Stanca CM， Fiel MI， Aledort L， et al. Factors associated with persistent thrombocytopenia after liver transplantation［J］. Transplant Proc， 2010， 42（5）：1769-1773.
|
| 14 |
Chang JH， Choi JY， Woo HY， et al. Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type［J］. World J Gastroenterol，2008， 14（37）：5723-5729.
|
| 15 |
贺健. 肝移植术后顽固性脾功能亢进预测因素的分析［D］. 天津：天津医科大学， 2019.
|
| 16 |
Kawano F， Ishizaki Y， Yoshimoto J， et al. Factors affecting persistent splenomegaly after adult-to-adult living donor liver transplantation using a left lobe［J］. Transplant Proc， 2019， 51（6）：1946-1949.
|
| 17 |
Nam NH， Taura K， Yao S， et al. Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study［J］. Transpl Int， 2020， 33（12）：1807-1820.
|
| 18 |
Kilambi R， Singh AN， Madhusudhan KS， et al. Portal hypertension and hypersplenism in extrahepatic portal venous obstruction：are they related？［J］. Indian J Gastroenterol， 2018， 37（3）：202-208.
|
| 19 |
Xue Z， Zhang X， Li Z， et al. Analysis of portal vein thrombosis after liver transplantation［J］. ANZ J Surg， 2019， 89（9）：1075-1079.
|
| 20 |
Masuda Y， Yoshizawa K， Ohno Y， et al. Small-for-size syndrome in liver transplantation：definition， pathophysiology and management［J］. Hepatobiliary Pancreat Dis Int， 2020， 19（4）：334-341.
|
| 21 |
Takahashi K， Nagai S， Safwan M， et al. Thrombocytopenia after liver transplantation：should we care？［J］. World J Gastroenterol，2018， 24（13）：1386-1397.
|
| 22 |
Schwabl P， Seeland BA， Riedl F， et al. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and noncirrhotic portal hypertension［J］. Adv Med Sci， 2022， 67（1）：154-162.
|
| 23 |
Qi RZ， Li ZW， Chang ZY， et al. Clinical efficacy of total laparoscopic splenectomy for portal hypertension and its influence on hepatic hemodynamics and liver function［J］. World J Gastrointest Surg， 2023， 15（8）：1684-1692.
|
| 24 |
Long B， Koyfman A， Gottlieb M. Complications in the adult asplenic patient：a review for the emergency clinician［J］. Am J Emerg Med，2021， 44：452-457.
|
| 25 |
Zhu J， Chen XJ， Hu XT，et al. A comparative study of surgical splenectomy， partial splenic embolization， and high-intensity focused ultrasound for hypersplenism［J］. J Ultrasound Med， 2016， 35（3）：467-474.
|
| 26 |
Huang Y， Ren D， Gao F， et al. An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis［J］. Minim Invasive Ther Allied Technol， 2022， 31（5）：664-675.
|
| 27 |
Slater SJ， Lukies M， Kavnoudias H， et al. Immune function and the role of vaccination after splenic artery embolization for blunt splenic injury［J］. Injury， 2022， 53（1）：112-115.
|
| 28 |
Capasso L， Moggio G， Camera A. Splenic artery embolization：a safety and save-life procedure in patient with acute leukemia，haemodynamically unstable because of haemoperitoneum［J］. Updates Surg， 2022， 74（4）：1489-1490.
|
| 29 |
Lee HL， Lee SW. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension：advantages and pitfalls［J］. Clin Mol Hepatol， 2022， 28（2）：121-134.
|
| 30 |
Jiang X， Gao F， Ma Y， et al. Percutaneous microwave ablation in the spleen for treatment of hypersplenism in cirrhosis patients［J］.Dig Dis Sci， 2016， 61（1）：287-292.
|
| 31 |
Zhang X， Tang S， Huang G， et al. Minimally invasive treatment of cirrhotic secondary hypersplenism with high-intensity focused ultrasound［J］. Sci Rep， 2022， 12（1）：20700.
|
| 32 |
Tefferi A. Primary myelofibrosis：2023 update on diagnosis， riskstratification， and management［J］. Am J Hematol， 2023， 98（5）：801-821.
|
| 33 |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis［J］. J Hepatol， 2022， 76（5）：1151-1184.
|
| 34 |
尹宇航， 许文涛， 何福亮， 等.《2022年欧洲肝病学会临床实践指南：预防和管理肝硬化患者出血和血栓形成》摘译［J］. 临床肝胆病杂志， 2022， 38（6）：4.
|
| 35 |
Roberts LN. How to manage hemostasis in patients with liver disease during interventions［J］. Hematology Am Soc Hematol Educ Program， 2023， （1）：274-280.
|
| 36 |
Evans CR， Cuker A， Crowther M， et al. Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease：a systematic review［J］. Res Pract Thromb Haemost， 2022， 6（4）：e12724.
|
| 37 |
Lindquist I， Olson SR， Li A， et al. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures：a systematic review and meta-analysis［J］. Platelets， 2022， 33（1）：66-72.
|
| 38 |
Nag HH， Chandrasekar S， Manipadum JM， et al. Laparoscopic splenic artery ligation for hypersplenism in cirrhosis：a case series［J］. J Minim Access Surg， 2016， 12（4）：334-337.
|
| 39 |
Jo HS， Yu YD， Choi YJ， et al. Left liver graft in adult-to-adult living donor liver transplantation with an optimal portal flow modulation strategy to overcome the small-for-size syndrome- a retrospective cohort study［J］. Int J Surg， 2022， 106：106953.
|
| 40 |
Usai S， Colasanti M， Meniconi RL， et al. Splenic artery steal syndrome after liver transplantation - prophylaxis or treatment？ A case report and literature review［J］. Ann Hepatobiliary Pancreat Surg，2022， 26（4）：386-394.
|
| 41 |
Jiang WT， Yang J， Xie Y， et al. Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism ［J］. World J Gastroenterol， 2021， 27（7）：654-665.
|
| 42 |
Boillot O， Chopinet S， Gregoire E， et al. Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism：a case control comparative study［J］. Clin Res Hepatol Gastroenterol， 2022， 46（6）：101929.
|
| 43 |
Sibulesky L， Nguyen JH， Paz-Fumagalli R， et al. Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C［J］. World J Gastroenterol， 2009， 15（40）：5010-5013.
|
| 44 |
D′Amico G， Partovi S， Del Prete L， et al. Proximal splenic artery embolization for refractory ascites and hydrothorax post-liver transplant［J］. Cardiovasc Intervent Radiol， 2023， 46（4）：470-479.
|
| 45 |
Ostojic A， Petrovic I， Silovski H， et al. Approach to persistent ascites after liver transplantation［J］. World J Hepatol， 2022， 14（9）：1739-1746.
|
| 46 |
Maruzzelli L， D′Amico M， Tuzzolino F， et al. Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients［J］. Eur Radiol， 2023， 33（4）：2612-2619.
|